{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:57:07Z","timestamp":1780534627842,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00822","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:53:20Z","timestamp":1590123200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"A.","family":"Ottria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van der Kroef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vazirpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Tieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G. K.","family":"Wichers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stigter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gulersonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bonte-Mineur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Berkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12916-016-0681-8","article-title":"Urine metabolome profiling of immune-mediated inflammatory diseases","volume":"14","author":"Juli\u00e0","year":"2016","journal-title":"BMC Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/jcm8091291","article-title":"Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases","volume":"8","author":"Bellocchi","year":"2019","journal-title":"J Clin Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.biocel.2017.07.004","article-title":"Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis","volume":"93","author":"Poddighe","year":"2017","journal-title":"Int J Biochem Cell Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e37210","DOI":"10.1371\/journal.pone.0037210","article-title":"Metabolic disturbances associated with systemic lupus erythematosus","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e44331","DOI":"10.1371\/journal.pone.0044331","article-title":"Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements","volume":"7","author":"van Wietmarschen","year":"2012","journal-title":"PLoS One."},{"key":"B7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","article-title":"Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension","volume":"241","author":"Deidda","year":"2017","journal-title":"Int J Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpba.2018.09.021","article-title":"Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients","volume":"162","author":"Fern\u00e1ndez-Ochoa","year":"2019","journal-title":"J Pharm Biomed Anal."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.1038\/s41598-018-25992-7","article-title":"Metabolomic profile of systemic sclerosis patients","volume":"8","author":"Murgia","year":"2018","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/annrheumdis-2018-214991","article-title":"Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis","volume":"78","author":"Affandi","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O'Neill","year":"2016","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.aca.2017.04.038","article-title":"Quantification of metabolites in dried blood spots by direct infusion high resolution mass spectrometry","volume":"979","author":"de","year":"2017","journal-title":"Anal Chim Acta."},{"key":"B15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature21673","article-title":"Interplay between metabolic identities in the intestinal crypt supports stem cell function","volume":"543","author":"Rodr\u00edguez-Colman","year":"2017","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","article-title":"MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data","volume":"11","author":"Pluskal","year":"2010","journal-title":"BMC Bioinform."},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jchromb.2013.01.012","article-title":"Development and validation of a quantitative LC-tandem MS assay for hexadeca-4,7,10,13-tetraenoic acid in human and mouse plasma","volume":"925","author":"Stigter","year":"2013","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4049\/jimmunol.1602020","article-title":"CXCL4 Exposure potentiates TLR-driven polarization of human monocyte-derived dendritic cells and increases stimulation of T cells","volume":"199","author":"Silva-Cardoso","year":"2017","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2019.07.004","article-title":"Fatty acid metabolites combine with reduced \u03b2 oxidation to activate Th17 inflammation in human type 2 diabetes","volume":"30","author":"Nicholas","year":"2019","journal-title":"Cell Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e66270","DOI":"10.1371\/journal.pone.0066270","article-title":"Inflammation and resolution are associated with upregulation of fatty acid \u03b2-oxidation in zymosan-induced peritonitis","volume":"8","author":"Fujieda","year":"2013","journal-title":"PLoS One."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","volume":"78","author":"Lee","year":"2010","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2012.08.086","article-title":"Inhibition of peroxisomal \u03b2-oxidation by thioridazine increases the amount of VLCFAs and A\u03b2 generation in the rat brain","volume":"528","author":"Shi","year":"2012","journal-title":"Neurosci Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-5793(85)81270-9","article-title":"Thioridazine: a selective inhibitor of peroxisomal \u03b2-oxidation in vivo","volume":"187","author":"Van den Branden","year":"1985","journal-title":"FEBS Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jbt.20208","article-title":"Interaction of mildronate with the mitochondrial carnitine\/acylcarnitine transport protein","volume":"22","author":"Oppedisano","year":"2008","journal-title":"J Biochem Mol Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.19723\/j.issn.1671-167X.2019.04.021","article-title":"Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms","volume":"51","author":"Zhu","year":"2019","journal-title":"Beijing Da Xue Xue Bao."},{"key":"B26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/nu10030349","article-title":"L-carnitine supplementation in recovery after exercise","volume":"10","author":"Fielding","year":"2018","journal-title":"Nutrients."},{"key":"B27","first-page":"383","article-title":"Acylcarnitines as translational biomarkers of mitochondrial dysfunction","volume-title":"Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants","author":"Beger","year":"2008"},{"key":"B28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.mam.2004.06.001","article-title":"Carnitine: transport and physiological functions in the brain","volume":"25","author":"Na\u0142ecz","year":"2004","journal-title":"Mol Aspects Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-5793(96)00603-5","article-title":"Palmitoylcarnitine, a surface-active metabolite","volume":"390","author":"Go\u00f1i","year":"1996","journal-title":"FEBS Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.R115.693903","article-title":"Immunometabolism: cellular metabolism turns immune regulator","volume":"291","author":"Loftus","year":"2016","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nri3771","article-title":"Dendritic cell metabolism","volume":"15","author":"Pearce","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","article-title":"Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype","volume":"289","author":"Freemerman","year":"2014","journal-title":"J Biol Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9029327","article-title":"HIF1 \u03b1-induced glycolysis metabolism is essential to the activation of inflammatory macrophages","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molimm.2015.07.036","article-title":"T cell metabolic reprogramming and plasticity","volume":"68","author":"Slack","year":"2015","journal-title":"Mol Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrneph.2014.244","article-title":"Dysfunctional fatty acid oxidation in renal fibrosis","volume":"11","author":"Allison","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","article-title":"Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism","volume":"9","author":"Angajala","year":"2018","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/cam4.1131","article-title":"Small cell lung carcinoma cell line screen of etoposide\/carboplatin plus a third agent","volume":"6","author":"Teicher","year":"2017","journal-title":"Cancer Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/DDDT.S92687","article-title":"Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species","volume":"10","author":"Papiez","year":"2016","journal-title":"Drug Des Devel Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/1535-7163.MCT-11-0980","article-title":"Inhibition of OCTN2-mediated transport of carnitine by etoposide","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cancer Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1568011054222364","article-title":"Etoposide, topoisomerase II and cancer","volume":"5","author":"Baldwin","year":"2005","journal-title":"Curr Med Chem Anticancer Agents."},{"key":"B41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/1744666X.2018.1465821","article-title":"Complications of adult-onset Still's disease and their management","volume":"14","author":"Mitrovic","year":"2018","journal-title":"Expert Rev Clin Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype","volume":"23","author":"Watson","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/ar2598","article-title":"Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis","volume":"11","author":"Beyer","year":"2009","journal-title":"Arthritis Res Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:53:24Z","timestamp":1590123204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2020.00822"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00822","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"article-number":"822"}}